Literature DB >> 21336522

Antimicrobial peptides with cell-penetrating peptide properties and vice versa.

Katrin Splith1, Ines Neundorf.   

Abstract

Antimicrobial peptides (AMPs) are a group of peptides that are active against a diverse spectrum of microorganisms. Due to their mode of action, AMPs are a promising class of molecules that could overcome the problems of increasing resistance of bacteria to conventional antibiotics. Furthermore, AMPs are strongly membrane-active and some are able to translocate into cells without the necessity for permanent membrane permeabilization. This feature has brought them into focus for use as transport vectors in the context of drug delivery. Since the plasma membrane restricts transport of bioactive substances into cells, great research interest lies in the development of innovative ways to overcome this barrier and to increase bioavailability. In this context, peptide-based transport systems, such as cell-penetrating peptides (CPPs), have come into focus, and their efficiency has been demonstrated in many different applications. However, more recently, also some AMPs have been used as efficient vectors for intracellular translocation of various active molecules. This review summarizes recent efforts in this interesting field of drug delivery. Moreover, some examples of the application of CPPs as efficient antimicrobial substances will be discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336522     DOI: 10.1007/s00249-011-0682-7

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  115 in total

Review 1.  Amphipathic, alpha-helical antimicrobial peptides.

Authors:  A Tossi; L Sandri; A Giangaspero
Journal:  Biopolymers       Date:  2000       Impact factor: 2.505

2.  Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity.

Authors:  D A Steinberg; M A Hurst; C A Fujii; A H Kung; J F Ho; F C Cheng; D J Loury; J C Fiddes
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore.

Authors:  K Matsuzaki; O Murase; N Fujii; K Miyajima
Journal:  Biochemistry       Date:  1995-05-16       Impact factor: 3.162

4.  Novel peptide conjugates for tumor-specific chemotherapy.

Authors:  M Langer; F Kratz; B Rothen-Rutishauser; H Wunderli-Allenspach; A G Beck-Sickinger
Journal:  J Med Chem       Date:  2001-04-26       Impact factor: 7.446

5.  Antimicrobial activity of rabbit CAP18-derived peptides.

Authors:  J W Larrick; M Hirata; Y Shimomoura; M Yoshida; H Zheng; J Zhong; S C Wright
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

6.  Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.

Authors:  J Turner; Y Cho; N N Dinh; A J Waring; R I Lehrer
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

7.  New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy.

Authors:  C Rousselle; P Clair; J M Lefauconnier; M Kaczorek; J M Scherrmann; J Temsamani
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

8.  Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity.

Authors:  C Rousselle; M Smirnova; P Clair; J M Lefauconnier; A Chavanieu; B Calas; J M Scherrmann; J Temsamani
Journal:  J Pharmacol Exp Ther       Date:  2001-01       Impact factor: 4.030

Review 9.  Antimicrobial peptides in mammalian and insect host defence.

Authors:  R I Lehrer; T Ganz
Journal:  Curr Opin Immunol       Date:  1999-02       Impact factor: 7.486

10.  Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells.

Authors:  Aparna Nori; Keith D Jensen; Monica Tijerina; Pavla Kopecková; Jindrich Kopecek
Journal:  Bioconjug Chem       Date:  2003 Jan-Feb       Impact factor: 4.774

View more
  66 in total

Review 1.  A common landscape for membrane-active peptides.

Authors:  Nicholas B Last; Diana E Schlamadinger; Andrew D Miranker
Journal:  Protein Sci       Date:  2013-06-11       Impact factor: 6.725

Review 2.  Snake venoms: attractive antimicrobial proteinaceous compounds for therapeutic purposes.

Authors:  Nelson Gomes de Oliveira Junior; Marlon Henrique e Silva Cardoso; Octavio Luiz Franco
Journal:  Cell Mol Life Sci       Date:  2013-05-09       Impact factor: 9.261

3.  Insights into buforin II membrane translocation from molecular dynamics simulations.

Authors:  Donald E Elmore
Journal:  Peptides       Date:  2012-09-26       Impact factor: 3.750

Review 4.  Modifications of natural peptides for nanoparticle and drug design.

Authors:  Andrew P Jallouk; Rohun U Palekar; Hua Pan; Paul H Schlesinger; Samuel A Wickline
Journal:  Adv Protein Chem Struct Biol       Date:  2015-03-12       Impact factor: 3.507

5.  Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake.

Authors:  Wei Huang; Jiwon Seo; Jennifer S Lin; Annelise E Barron
Journal:  Mol Biosyst       Date:  2012-10

6.  Effect of membrane potential on entry of lactoferricin B-derived 6-residue antimicrobial peptide into single Escherichia coli cells and lipid vesicles.

Authors:  Farzana Hossain; Hideo Dohra; Masahito Yamazaki
Journal:  J Bacteriol       Date:  2021-02-08       Impact factor: 3.490

Review 7.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

8.  Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization.

Authors:  Dania M Figueroa; Heidi M Wade; Katrina P Montales; Donald E Elmore; Louise E O Darling
Journal:  J Vis Exp       Date:  2018-08-11       Impact factor: 1.355

9.  Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection.

Authors:  Olaspers Sara Eriksson; Miriam Geörg; Hong Sjölinder; Rannar Sillard; Staffan Lindberg; Ulo Langel; Ann-Beth Jonsson
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

10.  Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers.

Authors:  Susan E Puckett; Kaleb A Reese; Georgi M Mitev; Valerie Mullen; Rudd C Johnson; Kyle R Pomraning; Brett L Mellbye; Lucas D Tilley; Patrick L Iversen; Michael Freitag; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2012-09-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.